Article Information
History
- April 10, 2020.
Article Versions
- Version 1 (March 27, 2020 - 05:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Andrew A. Lover*
- Department of Biostatistics and Epidemiology, University of Massachusetts-Amherst, Amherst, MA, alover{at}umass.edu
- Corresponding author; email: alover{at}umass.edu
Posted April 10, 2020.
Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial
